Release Date: 21/12/16 08:23 Summary: Atlas delivers positive results from Corunna Downs DFS Price Sensitive: Yes Download Document 2.7MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%